Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
Akihiro Ohmoto(Japanese Foundation For Cancer Research), Hermann Einsele(Universitätsklinikum Würzburg), Shigeo Fuji(National Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), Kendall C. Shultes(Unknown)
Cited by 18
Related Papers
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493